NCT07185165View on ClinicalTrials.gov

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 25, 2035

Study Completion Date

August 25, 2036

Conditions
Prostate Carcinoma
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

Fluorine F 18 Flotufolastat

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

PROCEDURE

Ultrasound-Guided Prostate Biopsy

Undergo PET/CT/ultrasound fusion biopsy

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

BLUE EARTH DIAGNOSTICS (UNITED KINGDOM)

UNKNOWN

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT07185165 - An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. | Biotech Hunter | Biotech Hunter